The Lancet Oncology Submission Advisor
Evaluates clinical oncology manuscripts for scope fit, evidence rigor, house style, and desk-reject risks when targeting The Lancet Oncology.
The Lancet Oncology Submission Advisor provides comprehensive editorial guidance for clinical researchers, oncologists, and epidemiologists targeting Elsevier's flagship cancer journal. It analyzes clinical trial data, cancer epidemiology studies, and oncology health-policy manuscripts against The Lancet Oncology's rigorous evidence thresholds—including CONSORT compliance, pre-registration standards, survival analysis requirements, and 'Added value of this study' panel formatting. By identifying desk-reject risks and suggesting strategic re-framing or alternate venues (such as JCO, Nature Medicine, or Cancer Discovery), this skill optimizes your paper for peer review and publication success.